HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Barney S Graham Selected Research

Respiratory Syncytial Virus Vaccines

10/2018The respiratory syncytial virus vaccine landscape: lessons from the graveyard and promising candidates.
12/2016Rapid profiling of RSV antibody repertoires from the memory B cells of naturally infected adult donors.
1/2011Biological challenges and technological opportunities for respiratory syncytial virus vaccine development.
5/2009TLR9 agonist, but not TLR7/8, functions as an adjuvant to diminish FI-RSV vaccine-enhanced disease, while either agonist used as therapy during primary RSV infection increases disease severity.
3/2002The role of IFN in respiratory syncytial virus pathogenesis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Barney S Graham Research Topics

Disease

85Infections
01/2022 - 01/2002
37Human Influenza (Influenza)
01/2022 - 12/2011
26Respiratory Syncytial Virus Infections
08/2021 - 02/2003
25COVID-19
03/2022 - 01/2020
14Virus Diseases (Viral Diseases)
01/2022 - 07/2005
9HIV Infections (HIV Infection)
01/2020 - 09/2004
7Pneumonia (Pneumonitis)
12/2021 - 05/2009
7Inflammation (Inflammations)
05/2021 - 04/2002
6Weight Loss (Weight Reduction)
10/2021 - 10/2004
6Zika Virus Infection
01/2020 - 01/2016
6Vaccinia
10/2016 - 06/2004
6Smallpox (Variola)
01/2011 - 06/2004
6Eosinophilia
09/2008 - 05/2002
5Communicable Diseases (Infectious Diseases)
01/2022 - 03/2014
5Pulmonary Eosinophilia (Eosinophilic Pneumonia)
09/2008 - 02/2003
4Severe Acute Respiratory Syndrome
11/2021 - 01/2020
4Viremia
12/2019 - 03/2016
4Respiratory Tract Infections (Respiratory Tract Infection)
01/2019 - 06/2011
4Ebola Hemorrhagic Fever
01/2017 - 04/2015
4Acquired Immunodeficiency Syndrome (AIDS)
11/2016 - 01/2002
3Coronavirus Infections
11/2021 - 01/2020
3Bronchiolitis
08/2021 - 11/2016
3Edema (Dropsy)
02/2021 - 01/2007
3Pain (Aches)
01/2019 - 04/2007
3Malaria
01/2017 - 09/2013
3Respiratory Hypersensitivity
12/2005 - 04/2002
2Headache (Headaches)
01/2022 - 10/2019
2Neoplasms (Cancer)
01/2019 - 08/2015
2Bites and Stings (Sting)
01/2019 - 09/2013
2Dengue (Dengue Fever)
01/2019 - 12/2017
2Sexually Transmitted Diseases (Sexually Transmitted Disease)
01/2019 - 12/2012
2Emerging Communicable Diseases (Emerging Infectious Diseases)
12/2017 - 09/2009
2Influenza in Birds (Avian Flu)
01/2017 - 04/2014
2Vesicular Stomatitis
01/2017 - 04/2016
2Parasitemia
01/2017 - 01/2016
2Fever (Fevers)
03/2016 - 02/2015
2Mpox (monkeypox)
12/2006 - 08/2006
1Flavivirus Infections
11/2021
1Asymptomatic Infections
11/2021
1Acute Lung Injury
10/2021

Drug/Important Bio-Agent (IBA)

109VaccinesIBA
01/2022 - 01/2002
32AntibodiesIBA
01/2022 - 03/2006
31Neutralizing AntibodiesIBA
12/2021 - 01/2002
24EpitopesIBA
03/2022 - 06/2004
19DNA (Deoxyribonucleic Acid)IBA
01/2022 - 06/2003
19Proteins (Proteins, Gene)FDA Link
11/2021 - 08/2006
18Hemagglutinins (Hemagglutinin)IBA
01/2022 - 09/2015
15AntigensIBA
12/2021 - 01/2011
14Influenza Vaccines (Influenza Vaccine)FDA Link
01/2022 - 12/2011
142019-nCoV Vaccine mRNA-1273IBA
12/2021 - 06/2020
12Broadly Neutralizing AntibodiesIBA
01/2022 - 12/2015
12Glycoproteins (Glycoprotein)IBA
11/2021 - 02/2003
12CytokinesIBA
02/2021 - 05/2002
11Monoclonal AntibodiesIBA
03/2022 - 03/2004
9Antiviral Agents (Antivirals)IBA
01/2021 - 09/2004
8DNA VaccinesIBA
12/2019 - 09/2009
8AIDS VaccinesIBA
01/2017 - 03/2006
7Interleukin-13IBA
09/2008 - 04/2002
6Formaldehyde (Formol)FDA Link
01/2019 - 03/2002
5Immunoglobulins (Immunoglobulin)IBA
01/2020 - 05/2015
5Respiratory Syncytial Virus VaccinesIBA
10/2018 - 03/2002
4COVID-19 VaccinesIBA
12/2021 - 01/2020
4RNA (Ribonucleic Acid)IBA
01/2019 - 05/2010
4Inactivated VaccinesIBA
01/2019 - 08/2013
4Peptides (Polypeptides)IBA
12/2017 - 08/2010
4Interleukin-5 (Interleukin 5)IBA
09/2008 - 02/2003
4AllergensIBA
12/2005 - 04/2002
3aluminum sulfate (alum)IBA
10/2021 - 01/2004
3Messenger RNA (mRNA)IBA
01/2021 - 09/2002
3Interleukin-4 (Interleukin 4)IBA
09/2008 - 02/2003
2DH1047IBA
01/2022 - 04/2021
2Viral ProteinsIBA
01/2022 - 01/2019
2bamlanivimabIBA
12/2021 - 10/2020
2Blocking AntibodiesIBA
02/2021 - 01/2021
2Fc Receptors (Fc Receptor)IBA
02/2021 - 01/2021
2Viral VaccinesIBA
01/2020 - 01/2020
2Immunoglobulin G (IgG)IBA
11/2019 - 01/2017
2A-Form DNA (A-DNA)IBA
10/2019 - 11/2013
2Ferritins (Ferritin)IBA
01/2019 - 11/2018
2Toll-Like Receptor AgonistsIBA
01/2019 - 05/2009
21- acetyl- 1,2,3,3a,8,8a- hexahydro- 8a- hydroxy- 5- methoxypyrrolo(2,3- b)indole (CHMI)IBA
01/2017 - 01/2016
2PalivizumabFDA Link
01/2017 - 02/2010
2Membrane Proteins (Integral Membrane Proteins)IBA
01/2017 - 10/2016
2T-Cell Antigen Receptors (T-Cell Receptor)IBA
04/2014 - 02/2011
2Respiratory syncytial virus G glycoproteinIBA
09/2008 - 02/2003
2Smallpox Vaccine (Vaccine, Smallpox)FDA Link
08/2006 - 06/2004
2Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA
12/2005 - 01/2005
2OvalbuminIBA
08/2004 - 04/2002
1N-methyl-valyl-amiclenomycin (BA 2)IBA
01/2022
1Neuraminidase (Sialidase)IBA
01/2022
1N-(2-cyanoethylene)urea (BA 1)IBA
01/2022
1Protein Subunit VaccinesIBA
10/2021
1Viral AntigensIBA
05/2021
1NanovaccinesIBA
01/2021
1Lipid NanoparticlesIBA
01/2021
1Immune Sera (Antisera)IBA
04/2020
1Polysaccharides (Glycans)IBA
01/2020

Therapy/Procedure

8Therapeutics
01/2020 - 03/2004
2Intramuscular Injections
11/2021 - 01/2021
2Injections
11/2021 - 01/2021